Canadian Climate Institute’s Early Estimate of National Emissions shows a drop of about 1 per cent in 2023, with Canada’s emissions now 8 per cent lower than 2005 levels. The latest Early Estimate of National Emissions(EENE) from the Canadian Climate Institute shows a modest improvement in national emissions in 2023, with a drop of about […]

Sirnaomics Ltd. (the “Company”, Stock Code: 2257, together with its subsidiaries,the “Group” or “Sirnaomics”), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today announced that the company in collaboration with Dr. Mark Nestor’s team from the Center for Clinical and Cosmetic Research in Miami Florida has jointly published a major

New messaging reflects TFS’s commitment to patient-centered clinical research and global partnerships TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), proudly announces the launch of its new mission statement and tagline: Empowering Partners. Enriching Lives. This strategic shift underscores TFS’s commitment to advancing clinical research, improving patient outcomes, and fostering sustainable partnerships. The

Garching / Munich, September 19, 2024 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced its participation in two upcoming industry investor conferences in New York City. ITM’s Chief Executive Officer, Dr. Andrew Cavey will deliver corporate presentations and participate in panel discussions, highlighting the Company’s broad, targeted radiopharmaceutical pipeline,

Sirnaomics Ltd. (the “Company”, Stock Code: 2257, together with its subsidiaries,the “Group” or “Sirnaomics”), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today announced that the company in collaboration with Dr. Mark Nestor’s team from the Center for Clinical and Cosmetic Research in Miami Florida has jointly published a major

1st cohort data demonstrates safety, feasibility and tolerability of the Everads Injector for delivering drugs to the back of the eye via thesuprachoroidal space Results validate use of the Injector in a clinical, office-based setting, and will supportthe clinical trial applications of Everads’ gene therapy license partners Everads Therapy,a clinical stage biotechnology company developing a

AON, Bertel O Steen, Capital One, Chick-fil-A, Danish Crown, Fidelity, Haleon, HP, and Whole Foods among Trintech customer presenters Trintech, a leading global provider of cloud-based financial close solutions for the Office of Finance, kicks off its annual Trintech Connect events this week designed to bring together Trintech’s global customers and partners to advance product

LibertySafe, the industry leader of USA-made home and gun safes, announces an upgrade to their beloved Franklin safe series. Updates include the all-new Pro Flex™ modular shelving system, premium leather-like interior, thicker steel for increased security, and a premium five-point Sure Tight handle. Available in three sizes and eight paint colors, the Franklin is an

Proposed Plans Would Transform Iconic Headquarters and Adjacent Property into a Dynamic Hub for Living, Working, Retail and Community Engagement Georgia-Pacific today announced initial plans for one of the country’s largest mixed-useredevelopments and the intent to transform its iconic 51-story world headquarters and the surrounding city block into a thriving center for innovation and community

SHENZHEN, China, Sept. 19, 2024 (GLOBE NEWSWIRE) — Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading insurance technology platform connecting consumers, insurance carriers and distribution partners digitally through data-driven and AI-powered solutions in Asia, today announced that it has partnered with New China Life Insurance Company Limited (“NCI”) to launch “Bliss